Edward Nirenberg on Nostr: In particular, there is a lot of imprecision with Novavax's estimate because there ...
In particular, there is a lot of imprecision with Novavax's estimate because there were so few cases to consider. It's also worth noting (if we're comparing Novavax to Moderna directly) that Novavax's placebo group also tends to have lower viral loads than Moderna's.
Published at
2024-09-15 15:30:20Event JSON
{
"id": "c664164fc9a9dd77b512efeef87e7930ff13241c42fc3603a29da8b573482dd9",
"pubkey": "c67b38e4c5023e985f04ae7ab6a6669cf463220e1b9ed54b897d1957004603a4",
"created_at": 1726414220,
"kind": 1,
"tags": [
[
"e",
"b9cca1a498f493429c3bc9357ab2abd2febc64b0ee5029c0a5d1a0449dfcef84",
"wss://relay.mostr.pub",
"reply"
],
[
"proxy",
"https://med-mastodon.com/users/enirenberg/statuses/113142282373801422",
"activitypub"
]
],
"content": "In particular, there is a lot of imprecision with Novavax's estimate because there were so few cases to consider. It's also worth noting (if we're comparing Novavax to Moderna directly) that Novavax's placebo group also tends to have lower viral loads than Moderna's.",
"sig": "3649fbcbf22cd0ed4db9598043f242d19bf31dd2799c3b0a4f4aebbbcfe1cc785c8206d052cdb20396d806b238acd274cd07430a04e6ab8b3e5c27dec2d8d822"
}
